ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 169 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $33,364,000 | -5.8% | 2,682,017 | +3.6% | 1.90% | -7.5% |
| Q3 2016 | $35,424,000 | +89.1% | 2,587,617 | +2.1% | 2.06% | +45.4% |
| Q2 2016 | $18,735,000 | +30.4% | 2,535,117 | +12.8% | 1.42% | +26.9% |
| Q1 2016 | $14,367,000 | +1.8% | 2,248,317 | -0.4% | 1.12% | +42.0% |
| Q4 2015 | $14,108,000 | +8.2% | 2,257,217 | +1.1% | 0.78% | +25.2% |
| Q3 2015 | $13,033,000 | -29.4% | 2,231,717 | 0.0% | 0.63% | -23.6% |
| Q2 2015 | $18,456,000 | +0.4% | 2,231,717 | 0.0% | 0.82% | -9.7% |
| Q1 2015 | $18,389,000 | +19.9% | 2,231,717 | 0.0% | 0.91% | +1.0% |
| Q4 2014 | $15,332,000 | +27.2% | 2,231,717 | 0.0% | 0.90% | 0.0% |
| Q3 2014 | $12,051,000 | -16.9% | 2,231,717 | -1.9% | 0.90% | -16.6% |
| Q2 2014 | $14,496,000 | -74.0% | 2,275,603 | -67.1% | 1.08% | -53.2% |
| Q1 2014 | $55,754,000 | +137.6% | 6,917,248 | +101.0% | 2.30% | +5.3% |
| Q4 2013 | $23,470,000 | – | 3,441,324 | – | 2.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
| Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
| Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
| Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
| Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
| Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
| Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
| PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
| HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |